Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
94.30    0.05 (0.05%)
Bid:
94.25
Ask:
94.45
Spread: 0.20 (0.212%)
Market Cap: £1.49b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Director/PDMR Shareholding

24 Jul 2017 15:30

RNS Number : 9292L
Sirius Real Estate Limited
24 July 2017
 

24 July 2017

Sirius Real Estate Limited

("Sirius Real Estate" or the "Company")

Director/PDMR Shareholding

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities, ("PDMR") and persons closely associate with them ("PCA").

 

On 7 July 2017, the following transactions by PDMRs took place according to the Company's Matching Share Plan ("MSP") in relation to the twelve months ending 31/03/2017, which is also the date that the MSP is being terminated.

 

Details of the shares awarded under the MSP are shown below:

 

PDMR

Number of Shares awarded

Share Price

Total holding of shares following acquisition

Andrew Coombs

132,605

£0.59

4,578,258

Alistair Marks

143,531

£0.59

2,628,568

Rudiger Swoboda

35,697

£0.59

443,059

 

The transactions were notified to the Company by the PDMRs on 24 July 2017.

 

This announcement, including the notifications below, has been made in accordance with the requirements of the EU Market Abuse Regulation.

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

 

Andrew Coombs

2

Reason for the notification

a)

Position/status

 

 

Chief Executive Officer

b)

Initial notification/Amendment

 

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sirius Real Estate Limited

b)

LEI

213800NURUF5W8QSK566

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of no par value

 

GG00B1W3VF54

b)

Nature of the transaction

 

 

Awarding of ordinary shares under the MSP for the twelve months ended 31/03/2017.

 

As a result, Andrew Coombs now has a beneficial interest in 4,578,258 shares representing 0.52% of the issued share capital.

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£0.59

132,605

d)

Aggregated information

- Aggregated volume

- Price

N/a single transaction

e)

Date of the transaction

 

24 July 2017

f)

Place of the transaction

 

London Stock Exchange (XLON); Main Market

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Alistair Marks

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sirius Real Estate Limited

b)

LEI

213800NURUF5W8QSK566

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

 

Ordinary shares of no par value

 

 

GG00B1W3VF54

b)

Nature of the transaction

 

 

Awarding of ordinary shares under the MSP for the twelve months ended 31/03/2017.

 

As a result, Alistair Marks now has a beneficial interest in 2,628,568 ordinary shares representing 0.3% of the issued share capital

c)

Price(s) and volume(s)

 

 

[In each case, please specify the currency and the metric for quantity.]

Price(s)

Volume(s)

£0.59

143,531

d)

Aggregated information

 - Aggregated volume

- Price

N/a single transaction

e)

Date of the transaction

24 July 2017

f)

Place of the transaction

 

London Stock Exchange (XLON); Main Market

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Rudiger Swoboda

2

Reason for the notification

a)

Position/status

 

Sales Director/PDMR

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sirius Real Estate Limited

b)

LEI

213800NURUF5W8QSK566

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

 

Ordinary shares of no par value

 

 

GG00B1W3VF54

b)

Nature of the transaction

 

 

Awarding of ordinary shares under the MSP for the twelve months ended 31/03/2017.

As a result, Rudiger Swoboda now has a beneficial interest in 443,059 ordinary shares, representing 0.05% of the issued share capital

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£0.59

35,697

d)

Aggregated information

 - Aggregated volume

- Price

 

N/a, single transaction

e)

Date of the transaction

 

24 July 2017

f)

Place of the transaction

 

 

London Stock Exchange (XLON); Main Market

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFFSDSISFID
Date   Source Headline
10th Jun 20164:44 pmRNSUpdate on Private and Secondary Placement
9th Jun 20167:00 amRNSProposed Private Placement and Acquisition
27th May 20163:48 pmRNSPosting of Scrip Circular and Reference Price
27th May 20167:00 amRNSDirector/PDMR Shareholding
25th May 20162:00 pmRNSDirector/PDMR Shareholding
23rd May 20167:00 amRNSFinal Results
5th May 20167:00 amRNSUpdate on Funding and Acquisitions
5th Apr 20167:00 amRNSCorrection - Trading Statement
4th Apr 20167:00 amRNSTrading Statement
29th Mar 20167:00 amRNSDirector/PDMR Shareholding
23rd Feb 20165:18 pmRNSHolding(s) in Company
16th Feb 20161:35 pmRNSHolding(s) in Company
15th Feb 20163:07 pmRNSHolding(s) in Company
29th Jan 20167:00 amRNSDirector's Dealing
20th Jan 20167:00 amRNSAdmission of Scrip Shares and Directors' Dealings
15th Jan 20167:00 amRNSScrip Allotment
17th Dec 20153:37 pmRNSResult of EGM
27th Nov 20153:35 pmRNSDirector Dealings
27th Nov 20153:30 pmRNSPosting of Scrip Circular and Reference Price
23rd Nov 20157:00 amRNSHalf Yearly Report
5th Nov 201512:01 pmRNSHolding(s) in Company
3rd Nov 20157:00 amRNSAcquisition update and date of results
23rd Oct 201511:21 amRNSHolding(s) in Company
6th Oct 20157:00 amRNSTrading Statement
11th Sep 20157:00 amRNSDirector/PDMR Shareholding
7th Sep 20157:00 amRNSTrading Update
18th Aug 201512:00 pmRNSDirectors' Dealings
31st Jul 20157:00 amRNSPosting of Annual Report
7th Jul 20154:47 pmRNSHolding(s) in Company
7th Jul 20152:00 pmRNSAllotment of Scrip Dividend
19th Jun 20157:00 amRNSChange of Adviser
17th Jun 20155:48 pmRNSHolding(s) in Company
17th Jun 20157:01 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSHolding(s) in Company
15th Jun 20154:39 pmRNSHolding(s) in Company
11th Jun 20152:00 pmRNSDirector/PDMR Shareholding
8th Jun 20153:29 pmRNSResults of Placing
4th Jun 201511:16 amRNSPlacing and Proposed Acquisition - Replacement
4th Jun 20157:00 amRNSPlacing and Proposed Acquisition
1st Jun 20157:00 amRNSScrip Dividend Reference Price and Conversion Rate
29th May 201511:30 amRNSPosting of Scrip Dividend Alternative Circular
22nd May 20157:00 amRNSFinal Results
13th May 20157:00 amRNSNotice of Results
1st Apr 20157:00 amRNSTrading Statement
27th Mar 20155:00 pmRNSDirectors' Dealings
11th Feb 20157:00 amRNSAcquisition
2nd Feb 20157:00 amRNSEnters FTSE AIM 100
8th Jan 20152:00 pmRNSDirectors' Dealings
2nd Jan 20157:00 amRNSScrip Allotment
22nd Dec 20147:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.